<DOC>
	<DOCNO>NCT02183090</DOCNO>
	<brief_summary>Study investigate pharmacokinetics tolerability intramuscular 15 mg meloxicam injection comparison 15 mg oral tablet</brief_summary>
	<brief_title>Pharmacokinetics Tolerability Meloxicam Injected Intramuscularly vs. Tablet Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Meloxicam</mesh_term>
	<criteria>Healthy subject determine result screen Written informed consent accordance Good Clinical Practice local legislation Age ≥ 18 ≤ 50 year Broca &gt; 20 % &lt; + 20 % Any find medical examination ( include laboratory , blood pressure , pulse rate electrocardiogram ( ECG ) ) deviate normal clinical relevance Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder Surgery gastrointestinal tract ( except appendectomy ) Diseases central nervous system ( epilepsy ) psychiatric disorder Chronic relevant acute infection Hypersensitivity meloxicam and/or nonsteroidal antirheumatic agent Intake drug long halflife ( &gt; 24 hour ) ( ≤ 1 month prior administration trial ) Use drug might influence result trial ( ≤ 10 day prior administration trial ) Participation another trial investigational drug ( ≤ 2 month prior administration trial ) Smoker ( &gt; = 10 cigarette &gt; = 3 cigar &gt; = 3 pipes/day ) Inability refrain smoke study day Known alcohol abuse Known drug abuse Blood donation ( ≤ 1 month prior administration ) Excessive physical activity ( ≤ 5 day prior administration ) History hemorrhagic diatheses History gastrointestinal ulcer , perforation bleed History bronchial asthma For female subject : Pregnancy Positive pregnancy test No adequate contraception e.g . sterilization , IUD ( intrauterine device ) , oral contraceptive Inability maintain adequate contraception whole study period Lactation period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>